Breast cancer is a heterogeneous disease generally comprised of five molecular subtypes: luminal A, luminal B, normal-like, HER-2 enriched, and basal-like1,2, with the last two subtypes having poorer prognosis and the highest TP53 mutation frequency2. The gene discussed is ERBB2; the disease is breast carcinoma.